166 related articles for article (PubMed ID: 37117082)
1. Gonadal tumors in a contemporary cohort of patients with differences in sex development undergoing surgery - A multi-site study from the Pediatric Urologic Oncology Working Group of the societies for pediatric urology.
Peard LM; Morin J; Flores V; Graham K; Taylor AS; Pope JC; Halstead V; Cost NG; Roberts EM; Makari JH; Cranford W; Saltzman AF
J Pediatr Urol; 2023 Aug; 19(4):399.e1-399.e8. PubMed ID: 37117082
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes of pre-malignant and invasive germ cell tumors in patients with differences in sex development - A systematic review.
Morin J; Peard L; Vanadurongvan T; Walker J; Dönmez Mİ; Saltzman AF
J Pediatr Urol; 2020 Oct; 16(5):576-582. PubMed ID: 32564942
[TBL] [Abstract][Full Text] [Related]
3. Frequency of gonadal tumours in complete androgen insensitivity syndrome (CAIS): A retrospective case-series analysis.
Chaudhry S; Tadokoro-Cuccaro R; Hannema SE; Acerini CL; Hughes IA
J Pediatr Urol; 2017 Oct; 13(5):498.e1-498.e6. PubMed ID: 28351649
[TBL] [Abstract][Full Text] [Related]
4. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis.
Wünsch L; Holterhus PM; Wessel L; Hiort O
BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217
[TBL] [Abstract][Full Text] [Related]
5. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
Pyle LC; Nathanson KL
Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
[TBL] [Abstract][Full Text] [Related]
6. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T
Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444
[TBL] [Abstract][Full Text] [Related]
7. Risk of gonadal neoplasia in patients with disorders/differences of sex development.
Slowikowska-Hilczer J; Szarras-Czapnik M; Duranteau L; Rapp M; Walczak-Jedrzejowska R; Marchlewska K; Oszukowska E; Nordenstrom A;
Cancer Epidemiol; 2020 Dec; 69():101800. PubMed ID: 32905884
[TBL] [Abstract][Full Text] [Related]
8. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
[TBL] [Abstract][Full Text] [Related]
9. Undetectable anti-Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis.
Hannema SE; Wolffenbuttel KP; van Bever Y; Brüggenwirth HT; van den Berg SAA; Hersmus R; Oosterhuis JW; Looijenga LHJ
Clin Endocrinol (Oxf); 2023 Jul; 99(1):58-63. PubMed ID: 36905105
[TBL] [Abstract][Full Text] [Related]
10. Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States.
Siebert AL; Gomez-Lobo V; Johnson EK; Nahata L; Orwig KE; Pyle LC; Witchel SF; Finlayson C; Laronda MM
Front Endocrinol (Lausanne); 2022; 13():990359. PubMed ID: 36733807
[TBL] [Abstract][Full Text] [Related]
11. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development.
Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E
Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164
[TBL] [Abstract][Full Text] [Related]
13. Normal pelvic ultrasound or MRI does not rule out neoplasm in patients with gonadal dysgenesis and Y chromosome material.
Ebert KM; Hewitt GD; Indyk JA; McCracken KA; Nahata L; Jayanthi VR
J Pediatr Urol; 2018 Apr; 14(2):154.e1-154.e6. PubMed ID: 29317190
[TBL] [Abstract][Full Text] [Related]
14. Gonadal Tissue Cryopreservation for Children with Differences of Sex Development.
Johnson EK; Finlayson C; Finney EL; Harris CJ; Tan SY; Laronda MM; Lockart BA; Chen D; Rowell EE; Cheng EY; Yerkes EB
Horm Res Paediatr; 2019; 92(2):84-91. PubMed ID: 31509845
[TBL] [Abstract][Full Text] [Related]
15. Malignant Germ Cell Tumors and Their Precursor Gonadal Lesions in Patients with XY-DSD: A Case Series and Review of the Literature.
Steinmacher S; Brucker SY; Kölle A; Krämer B; Schöller D; Rall K
Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34070473
[TBL] [Abstract][Full Text] [Related]
16. Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence.
Huang H; Wang C; Tian Q
Clin Endocrinol (Oxf); 2017 Apr; 86(4):621-627. PubMed ID: 27862157
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, distribution, and risk markers for the development of gonadal germ cell tumors in patients with certain types of disorders of sexual differentiation with Y chromosome - A retrospective study.
Das DV; Jabbar PK; Gomez R; Nambisan B; Bhuvitha MS; Nair A; Jayakumari C
Indian J Cancer; 2023 Oct; 60(4):464-474. PubMed ID: 38078466
[TBL] [Abstract][Full Text] [Related]
18. Is a CIS phenotype apparent in children with Disorders of Sex Development? Milder testicular dysgenesis is associated with a higher risk of malignancy.
Chemes HE; Venara M; Del Rey G; Arcari AJ; Musse MP; Papazian R; Forclaz V; Gottlieb S
Andrology; 2015 Jan; 3(1):59-69. PubMed ID: 25598272
[TBL] [Abstract][Full Text] [Related]
19. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
[TBL] [Abstract][Full Text] [Related]
20. Turner Syndrome with Y Chromosome: Spontaneous Thelarche, Menarche, and Risk of Malignancy.
Dabrowski E; Johnson EK; Patel V; Hsu Y; Davis S; Goetsch AL; Habiby R; Brickman WJ; Finlayson C
J Pediatr Adolesc Gynecol; 2020 Feb; 33(1):10-14. PubMed ID: 31465855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
